Sign Up For Updates
My RWC:  

Biosimilars for Retinal Diseases 

SIG Chair: Ashish Sharma, MD

Aim:

  • To strengthen International Retinal Biosimilar Study (Inter- BIOS) Group by involving ranibizumab biosimilar users and thought leaders across the globe
  • To publish real world data of ranibizumab biosimilars across the globe under one platform of Inter-BIOS Group

Background:

International Retinal Biosimilar Study (Inter- BIOS) Group was formed in 2022 and conducted the first study as an awareness survey entitled “Biosimilars for Retinal Diseases – United States-Europe Awareness Survey (Bio-USER –Survey).” Results of the survey were presented at Euretina 2022 and AAO 2022.

Be one of the first to receive more information by creating a “My RWC” account here:  https://retinaworldcongress.org/register/